Argent Trust CO United Therapeutics Corp Transaction History

Argent Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $57,294 - $74,289	-269 Reduced 21.1%	1,006 $225,000
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $49,839 - $67,864	242 Added 23.43%	1,275 $354,000
Q3 2022 Nov 10, 2022	BUY	$203.3 - $244.17 $15,044 - $18,068	74 Added 7.72%	1,033 $217,000
Q2 2022 Aug 11, 2022	BUY	$174.81 - $241.14 $167,642 - $231,253	959 New	959 $226,000
Q1 2022 May 11, 2022	SELL	$166.16 - $213.96 $169,483 - $218,239	-1,020 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$184.32 - $216.08 $188,006 - $220,401	1,020 New	1,020 $221,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.